{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:45:27Z","timestamp":1776113127241,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360526"],"award-info":[{"award-number":["82360526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejrad.2026.112784","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:26:05Z","timestamp":1773249965000},"page":"112784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multimodal therapeutic efficacy model for predicting early treatment response to TACE-HAIC combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in unresectable hepatocellular carcinoma"],"prefix":"10.1016","volume":"199","author":[{"given":"Yangyang","family":"Ou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haizhao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanneng","family":"Nong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji \u2019an","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihe","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2026.112784_b0005","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0010","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.3390\/biomedicines10123202","article-title":"Pathogenesis and current treatment strategies of hepatocellular carcinoma","volume":"10","author":"T\u00fcmen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejrad.2026.112784_b0015","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma, J. Hepatol. 82 (2025) 315-374.","DOI":"10.1016\/j.jhep.2024.08.028"},{"key":"10.1016\/j.ejrad.2026.112784_b0020","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.3390\/curroncol30100633","article-title":"The new era of systemic treatment for hepatocellular carcinoma: from the first line to the optimal sequence","volume":"30","author":"Cerreto","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0025","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3748\/wjg.v30.i18.2479","article-title":"Options and survival benefits of conversion therapy for unresectable hepatocellular carcinoma","volume":"30","author":"She","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2026.112784_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112492","article-title":"Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma","volume":"137","author":"Pang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejrad.2026.112784_b0035","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/JS9.0000000000000256","article-title":"TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study","volume":"109","author":"Yuan","year":"2023","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2026.112784_b0040","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1097\/JS9.0000000000002890","article-title":"Sequential HAIC-TACE combined with targeted and immunotherapy in hepatocellular carcinoma: a quality improvement study","volume":"111","author":"Wan","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2026.112784_b0045","first-page":"758","article-title":"Current perspectives on perioperative combination therapy for hepatocellular carcinoma","volume":"14","author":"Nishio","year":"2025","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejrad.2026.112784_b0050","article-title":"Radiomics in breast cancer: current advances and future directions","volume":"5","author":"Qi","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejrad.2026.112784_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111297","article-title":"Radiomics and liver: where we are and where we are headed?","volume":"171","author":"Maino","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2026.112784_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12876-024-03555-7","article-title":"Deep learning-based CT radiomics predicts prognosis of unresectable hepatocellular carcinoma treated with TACE-HAIC combined with PD-1 inhibitors and tyrosine kinase inhibitors","volume":"25","author":"Yin","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ejrad.2026.112784_b0065","article-title":"Research progress of MRI-based radiomics in hepatocellular carcinoma","volume":"15","author":"Xie","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0070","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.acra.2024.09.061","article-title":"Efficacy and safety of HAIC-FOLFOX plus tyrosine kinase inhibitors and immune checkpoint inhibitors as first-line treatment for unresectable advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"32","author":"Jiang","year":"2025","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2026.112784_b0075","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1002\/cam4.5880","article-title":"Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: Amulticenter, retrospective study","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejrad.2026.112784_b0080","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1097\/JS9.0000000000001752","article-title":"Multimodal imaging-based prediction of recurrence for unresectable HCC after downstage and resection-cohort study","volume":"110","author":"Jiang","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2026.112784_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/rcs.70004","article-title":"DSA-Former: a network of hybrid variable structures for liver and liver tumour segmentation","volume":"20","author":"Qin","year":"2024","journal-title":"Int. J. Med. Robot."},{"key":"10.1016\/j.ejrad.2026.112784_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-022-00457-3","article-title":"Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos","volume":"22","author":"Zhang","year":"2022","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ejrad.2026.112784_b0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.21037\/jgo-23-821","article-title":"Comparative study on the efficacy and safety of transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for large unresectable hepatocellular carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejrad.2026.112784_b0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s43556-024-00184-0","article-title":"Signaling pathways in liver cancer: pathogenesis and targeted therapy","volume":"5","author":"Xue","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ejrad.2026.112784_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1664756","article-title":"TACE-HAIC versus HAIC combined with TKIs and ICIs for hepatocellular carcinoma with a high tumor burden-a propensity-score matching comparative study","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.112784_b0115","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1097\/JS9.0000000000002818","article-title":"Comparison of the efficacy and safety of TACE-HAIC-MTTs-ICIs and TACE-MTTs-ICIs in the hepatocellular carcinoma: a prognostic analysis based on the dynamic changes of serum AFP","volume":"111","author":"Li","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ejrad.2026.112784_b0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.annonc.2024.03.005","article-title":"Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040","volume":"35","author":"Melero","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1421520","article-title":"Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis","volume":"15","author":"Fang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.112784_b0130","first-page":"760","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice, Lancet","volume":"8","author":"Pinter","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2026.112784_b0135","article-title":"Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances","volume":"16","author":"Xie","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejrad.2026.112784_b0140","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.3390\/cancers15205046","article-title":"Unveiling the role of tumor-infiltrating T cells and immunotherapy in hepatocellular carcinoma: a comprehensive review","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejrad.2026.112784_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.764189","article-title":"Response evaluation and survival prediction following PD-1 Inhibitor in patients with advanced hepatocellular carcinoma: comparison of the RECIST 1.1, iRECIST, and mRECIST criteria","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","article-title":"mRECIST for HCC: performance and novel refinements","volume":"72","author":"Llovet","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2026.112784_b0155","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11547-024-01840-9","article-title":"Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"129","author":"Deng","year":"2024","journal-title":"Radiol. Med."},{"key":"10.1016\/j.ejrad.2026.112784_b0160","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/j.acra.2025.02.042","article-title":"Quantitative magnetic resonance imaging methods for the assessment and prediction of treatment response to transarterial chemoembolization in hepatocellular carcinoma","volume":"32","author":"Zhang","year":"2025","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejrad.2026.112784_b0165","doi-asserted-by":"crossref","first-page":"34782","DOI":"10.1038\/s41598-025-18586-7","article-title":"Predicting the outcome of transarterial chemoembolization combined with targeted immunotherapy for unresectable hepatocellular carcinoma based on MRI radiomics","volume":"15","author":"Liu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2026.112784_b0170","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s13402-025-01041-0","article-title":"Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi-center retrospective study","volume":"48","author":"Wu","year":"2025","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejrad.2026.112784_b0175","doi-asserted-by":"crossref","DOI":"10.2196\/28880","article-title":"Using a convolutional neural network and convolutional long short-term memory to automatically detect aneurysms on 2D digital subtraction angiography images: framework development and validation","volume":"10","author":"Liao","year":"2022","journal-title":"JMIR Med. Inform."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:30:14Z","timestamp":1776108614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S0720048X26001324"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.112784","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal therapeutic efficacy model for predicting early treatment response to TACE-HAIC combined with immune checkpoint inhibitors and tyrosine kinase inhibitors in unresectable hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.112784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112784"}}